Montgomery Pamela W. 4

What Happened
Pamela W. Montgomery, Chief Legal Officer — Healthcare at Nutex Health, had 2,084 restricted stock units (RSUs) convert into 2,084 common shares on March 10, 2026 (acquired at $0 exercise price). To satisfy tax withholding, 776 of those shares were sold at $86.22 each for total proceeds of $66,909. Montgomery retained the remaining 1,308 vested shares. Separately, she was granted 1,525 new RSUs (see footnote) that vest in three equal installments on March 1, 2027, 2028 and 2029.

Key Details

• Transaction dates: vest/conversion and sell-to-cover on 2026-03-10; RSU grant noted 2026-03-11.
• Vesting/conversion: 2,084 shares acquired at $0.00 (code M = conversion of derivative).
• Sale for tax withholding: 776 shares sold at $86.22 each for $66,909 (code F = tax withholding).
• Shares retained after the sell-to-cover: 1,308 vested shares.
• New grant: 1,525 RSUs granted, vesting in three equal installments on Mar 1, 2027–2029 (per footnote).
• Filing: Form 4 filed 2026-03-11 — reported within SEC timeliness rules (not late).
• Notes: The sale was a sell-to-cover for taxes (routine); no cash was paid to acquire the vested shares (exercise price $0).

Context
This filing reflects compensation-related activity (vested RSUs and a new RSU grant) and a routine sell-to-cover for tax withholding. Such transactions are common when awards vest and do not necessarily signal the insider’s view of the company’s near-term prospects. Purchases by insiders are generally more informative about bullish sentiment than routine vesting and sell-to-cover events.